Develops precise gene therapies to treat neurological disorders by targeting and regulating genes for lasting, transformative benefits.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Encoded Therapeutics develops genetic medicines designed to address the root causes of neurological disorders, aiming to deliver long-lasting and transformative benefits. The company uses a novel targeting and regulation platform to create gene therapies with increased specificity, cell selectivity, and potency, overcoming challenges faced by first-generation gene therapies.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Encoded Therapeutics Management Team
Investors
Alexandria Venture Investments
Altitude Life Science Ventures
ARCH Venture Partners
Boxer Capital LLC
Braidwell LP
Farallon Capital Management LLC
Google Ventures
HBM Genomics
Illumina, Inc.
Janus Henderson
Matrix Capital Management
Matrix Partners
Menlo Ventures
Meritech Capital
Nolan Capital, Inc.
RTW Investments
Softbank Capital
The Invus Group LLC
Venrock, Inc.
Encoded Therapeutics Valuations & Financials
View real-time NPM data on Encoded Therapeutics stock including daily Encoded Therapeutics stock price estimates, valuation history, and historical share price information. Access Encoded Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Encoded Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Encoded Therapeutics? Get in touch to learn more.
Similar Companies
like Encoded Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
HALO Precision Diagnostics
Healthcare & Life Sciences
Delivers health insights which enhance early detection and personalize treatment pathways.
Cattle Guru
E-commerce platform delivers premium cattle feed and services to dairy farmers, offering doorstep delivery and quality testing.
ParentSquare
Consumer
Communication platform that enables smooth interaction between schools and families.
Monterra
Delivers AI-powered solutions to automate workflows, optimize operations, and enhance decision-making for businesses across industries.
American Giant
Consumer
Delivers premium, durable apparel made entirely in the USA, focusing on quality and ethical production practices.
LoginID
Delivers passwordless, passkey-based authentication for secure, seamless user logins and transaction confirmations across digital platforms.
Innovapptive
Enterprise Software
A leading provider of connected worker solutions that integrates frontline operations with enterprise systems to improve efficiency and data accuracy.
bKash
Mobile financial services platform enabling digital transactions, money transfers, and bill payments via phones to promote financial inclusion.
FAQ
We have answers
Encoded Therapeutics stock does not trade on public stock exchanges. Encoded Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Encoded Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Encoded Therapeutics Stock does not trade on public stock exchanges. In order to sell Encoded Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Encoded Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Encoded Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Encoded Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Encoded Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Encoded Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Encoded Therapeutics is a private company and has not had an IPO. There is currently no Encoded Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Encoded Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
